While much of the nation was tuned into the Michael Cohen drama in Washington, D.C. this week, another drama was playing out in a San Francisco courtroom.
On February 25, a jury in San Francisco Federal Court began hearing the case of Edwin Hardeman vs. Monsanto. Hardeman alleges that Monsanto’s Roundup weedkiller caused his non-Hodgkin lymphoma cancer.
Hardeman’s is the second case involving someone who developed non-Hodgkin lymphoma after using Roundup. His case follows the August 10, 2018, $289-million judgment (later reduced to $78 million) awarded to DeWayne “Lee” Johnson, a former school groundskeeper who also sued Monsanto for causing his non-Hodgkin lymphoma. Monsanto’s appeal of the $78-million judgment is still pending.
There are more than 9,000 claims pending against Monsanto in state courts, about 620 awaiting trial in federal court. Reuters reported in November that Hardeman’s case was selected as “a so-called bellwether, or test trial, frequently used in U.S. product liability mass litigation to help both sides gauge the range of damages and define settlement options.”